ρ0 Tumor cells: A model for studying whether mitochondria are targets for rhodamine 123, doxorubicin, and other drugs

Yan Ping Hu, Carlos T Moraes, Niramol Savaraj, Waldemar Priebe, Theodore Lampidis

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

A human osteosarcoma cell line devoid of mitochondrial DNA (ρ0) and its wild-type parental cell counterpart (wt) are presented as a model to investigate drug targeting. By virtue of the absence of mitochondrial DNA, ρ0 cells cannot perform electron transport or oxidative phosphorylation. Since most of the drugs studied are transported by the efflux pumping systems controlled by the MDR1 and MRP1 genes, both cell lines were examined for the expression of these genes, and it was found that no MDR1 and only low amounts of MRP1 were expressed. Growth inhibition experiments indicated that doxorubicin (Dox), vinblastine, and paclitaxel were equitoxic in these cell lines. On the other hand, the IC50 for rhodamine 123 (Rho 123) in ρ0 cells was 50 times higher than in wt cells. This result correlates with a lower accumulation of Rho 123 in ρ0 cells as measured by fluorescence microscopy and flow cytometry (3 times less than in wt cells). In contrast, when stained with Dox, both cell types accumulated similar amounts. Surprisingly, in these non-P-glycoprotein expressing cells, verapamil increased both Dox and Rho 123 retention. Overall, these data suggest that: (i) functional mitochondria do not appear to be targets for the growth inhibitory activities of Dox, paclitaxel, or vinblastine; (ii) for lipophilic cations like Rho 123, however, normal functioning mitochondria and maintenance of a normal mitochondrial membrane potential (ΔΨ(mt)) appear to play a critical role in the intracellular accumulation and subsequent cytotoxicities of these compounds; and (iii) verapamil increases drug accumulation in non-P-glycoprotein expressing cell lines, most likely by direct action on ΔΨ(mt) for Rho 123 and safranin O, and on heretofore unidentified plasma membrane transporters, as well as via interaction with low levels of MRP1, for Dox. These results should be considered when Rho 123 and verapamil are used to detect P-glycoprotein. (C) 2000 Elsevier Science Inc.

Original languageEnglish
Pages (from-to)1897-1905
Number of pages9
JournalBiochemical Pharmacology
Volume60
Issue number12
DOIs
StatePublished - Dec 15 2000

Fingerprint

Rhodamine 123
Mitochondria
Doxorubicin
Tumors
Cells
Verapamil
Pharmaceutical Preparations
Neoplasms
Vinblastine
Paclitaxel
Mitochondrial DNA
Cell Line
Glycoproteins
Genes
Membrane Transport Proteins
Flow cytometry
Fluorescence microscopy
P-Glycoprotein
Cell membranes
Cytotoxicity

Keywords

  • ρ Cells
  • Doxorubicin
  • Mitochondria
  • Non-P-glycoprotein cells
  • Rhodamine 123

ASJC Scopus subject areas

  • Pharmacology

Cite this

ρ0 Tumor cells : A model for studying whether mitochondria are targets for rhodamine 123, doxorubicin, and other drugs. / Hu, Yan Ping; Moraes, Carlos T; Savaraj, Niramol; Priebe, Waldemar; Lampidis, Theodore.

In: Biochemical Pharmacology, Vol. 60, No. 12, 15.12.2000, p. 1897-1905.

Research output: Contribution to journalArticle

@article{22ff75d470d342d58a145d2046e8c25c,
title = "ρ0 Tumor cells: A model for studying whether mitochondria are targets for rhodamine 123, doxorubicin, and other drugs",
abstract = "A human osteosarcoma cell line devoid of mitochondrial DNA (ρ0) and its wild-type parental cell counterpart (wt) are presented as a model to investigate drug targeting. By virtue of the absence of mitochondrial DNA, ρ0 cells cannot perform electron transport or oxidative phosphorylation. Since most of the drugs studied are transported by the efflux pumping systems controlled by the MDR1 and MRP1 genes, both cell lines were examined for the expression of these genes, and it was found that no MDR1 and only low amounts of MRP1 were expressed. Growth inhibition experiments indicated that doxorubicin (Dox), vinblastine, and paclitaxel were equitoxic in these cell lines. On the other hand, the IC50 for rhodamine 123 (Rho 123) in ρ0 cells was 50 times higher than in wt cells. This result correlates with a lower accumulation of Rho 123 in ρ0 cells as measured by fluorescence microscopy and flow cytometry (3 times less than in wt cells). In contrast, when stained with Dox, both cell types accumulated similar amounts. Surprisingly, in these non-P-glycoprotein expressing cells, verapamil increased both Dox and Rho 123 retention. Overall, these data suggest that: (i) functional mitochondria do not appear to be targets for the growth inhibitory activities of Dox, paclitaxel, or vinblastine; (ii) for lipophilic cations like Rho 123, however, normal functioning mitochondria and maintenance of a normal mitochondrial membrane potential (ΔΨ(mt)) appear to play a critical role in the intracellular accumulation and subsequent cytotoxicities of these compounds; and (iii) verapamil increases drug accumulation in non-P-glycoprotein expressing cell lines, most likely by direct action on ΔΨ(mt) for Rho 123 and safranin O, and on heretofore unidentified plasma membrane transporters, as well as via interaction with low levels of MRP1, for Dox. These results should be considered when Rho 123 and verapamil are used to detect P-glycoprotein. (C) 2000 Elsevier Science Inc.",
keywords = "ρ Cells, Doxorubicin, Mitochondria, Non-P-glycoprotein cells, Rhodamine 123",
author = "Hu, {Yan Ping} and Moraes, {Carlos T} and Niramol Savaraj and Waldemar Priebe and Theodore Lampidis",
year = "2000",
month = "12",
day = "15",
doi = "10.1016/S0006-2952(00)00513-X",
language = "English",
volume = "60",
pages = "1897--1905",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - ρ0 Tumor cells

T2 - A model for studying whether mitochondria are targets for rhodamine 123, doxorubicin, and other drugs

AU - Hu, Yan Ping

AU - Moraes, Carlos T

AU - Savaraj, Niramol

AU - Priebe, Waldemar

AU - Lampidis, Theodore

PY - 2000/12/15

Y1 - 2000/12/15

N2 - A human osteosarcoma cell line devoid of mitochondrial DNA (ρ0) and its wild-type parental cell counterpart (wt) are presented as a model to investigate drug targeting. By virtue of the absence of mitochondrial DNA, ρ0 cells cannot perform electron transport or oxidative phosphorylation. Since most of the drugs studied are transported by the efflux pumping systems controlled by the MDR1 and MRP1 genes, both cell lines were examined for the expression of these genes, and it was found that no MDR1 and only low amounts of MRP1 were expressed. Growth inhibition experiments indicated that doxorubicin (Dox), vinblastine, and paclitaxel were equitoxic in these cell lines. On the other hand, the IC50 for rhodamine 123 (Rho 123) in ρ0 cells was 50 times higher than in wt cells. This result correlates with a lower accumulation of Rho 123 in ρ0 cells as measured by fluorescence microscopy and flow cytometry (3 times less than in wt cells). In contrast, when stained with Dox, both cell types accumulated similar amounts. Surprisingly, in these non-P-glycoprotein expressing cells, verapamil increased both Dox and Rho 123 retention. Overall, these data suggest that: (i) functional mitochondria do not appear to be targets for the growth inhibitory activities of Dox, paclitaxel, or vinblastine; (ii) for lipophilic cations like Rho 123, however, normal functioning mitochondria and maintenance of a normal mitochondrial membrane potential (ΔΨ(mt)) appear to play a critical role in the intracellular accumulation and subsequent cytotoxicities of these compounds; and (iii) verapamil increases drug accumulation in non-P-glycoprotein expressing cell lines, most likely by direct action on ΔΨ(mt) for Rho 123 and safranin O, and on heretofore unidentified plasma membrane transporters, as well as via interaction with low levels of MRP1, for Dox. These results should be considered when Rho 123 and verapamil are used to detect P-glycoprotein. (C) 2000 Elsevier Science Inc.

AB - A human osteosarcoma cell line devoid of mitochondrial DNA (ρ0) and its wild-type parental cell counterpart (wt) are presented as a model to investigate drug targeting. By virtue of the absence of mitochondrial DNA, ρ0 cells cannot perform electron transport or oxidative phosphorylation. Since most of the drugs studied are transported by the efflux pumping systems controlled by the MDR1 and MRP1 genes, both cell lines were examined for the expression of these genes, and it was found that no MDR1 and only low amounts of MRP1 were expressed. Growth inhibition experiments indicated that doxorubicin (Dox), vinblastine, and paclitaxel were equitoxic in these cell lines. On the other hand, the IC50 for rhodamine 123 (Rho 123) in ρ0 cells was 50 times higher than in wt cells. This result correlates with a lower accumulation of Rho 123 in ρ0 cells as measured by fluorescence microscopy and flow cytometry (3 times less than in wt cells). In contrast, when stained with Dox, both cell types accumulated similar amounts. Surprisingly, in these non-P-glycoprotein expressing cells, verapamil increased both Dox and Rho 123 retention. Overall, these data suggest that: (i) functional mitochondria do not appear to be targets for the growth inhibitory activities of Dox, paclitaxel, or vinblastine; (ii) for lipophilic cations like Rho 123, however, normal functioning mitochondria and maintenance of a normal mitochondrial membrane potential (ΔΨ(mt)) appear to play a critical role in the intracellular accumulation and subsequent cytotoxicities of these compounds; and (iii) verapamil increases drug accumulation in non-P-glycoprotein expressing cell lines, most likely by direct action on ΔΨ(mt) for Rho 123 and safranin O, and on heretofore unidentified plasma membrane transporters, as well as via interaction with low levels of MRP1, for Dox. These results should be considered when Rho 123 and verapamil are used to detect P-glycoprotein. (C) 2000 Elsevier Science Inc.

KW - ρ Cells

KW - Doxorubicin

KW - Mitochondria

KW - Non-P-glycoprotein cells

KW - Rhodamine 123

UR - http://www.scopus.com/inward/record.url?scp=0034672530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034672530&partnerID=8YFLogxK

U2 - 10.1016/S0006-2952(00)00513-X

DO - 10.1016/S0006-2952(00)00513-X

M3 - Article

C2 - 11108806

AN - SCOPUS:0034672530

VL - 60

SP - 1897

EP - 1905

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 12

ER -